nodes	percent_of_prediction	percent_of_DWPC	metapath
Duloxetine—HTR6—schizophrenia	0.243	0.306	CbGaD
Duloxetine—SLC6A3—schizophrenia	0.125	0.157	CbGaD
Duloxetine—HTR2C—schizophrenia	0.112	0.141	CbGaD
Duloxetine—SLC6A4—schizophrenia	0.0931	0.117	CbGaD
Duloxetine—CYP1A2—schizophrenia	0.0848	0.107	CbGaD
Duloxetine—HTR2A—schizophrenia	0.0716	0.09	CbGaD
Duloxetine—CYP2D6—schizophrenia	0.0654	0.0823	CbGaD
Duloxetine—SLC6A2—locus ceruleus—schizophrenia	0.00602	0.0773	CbGeAlD
Duloxetine—HTR2A—locus ceruleus—schizophrenia	0.00362	0.0464	CbGeAlD
Duloxetine—SLC6A3—telencephalic ventricle—schizophrenia	0.00354	0.0454	CbGeAlD
Duloxetine—HTR2C—telencephalic ventricle—schizophrenia	0.00342	0.0439	CbGeAlD
Duloxetine—SLC6A2—autonomic nervous system—schizophrenia	0.0032	0.0411	CbGeAlD
Duloxetine—HTR2A—cerebellar cortex—schizophrenia	0.00295	0.0379	CbGeAlD
Duloxetine—NPY1R—forebrain—schizophrenia	0.0022	0.0282	CbGeAlD
Duloxetine—HTR2A—pons—schizophrenia	0.00209	0.0268	CbGeAlD
Duloxetine—NPY1R—telencephalon—schizophrenia	0.00202	0.0259	CbGeAlD
Duloxetine—CYP1A2—urine—schizophrenia	0.002	0.0257	CbGeAlD
Duloxetine—HTR2A—autonomic nervous system—schizophrenia	0.00192	0.0247	CbGeAlD
Duloxetine—HTR2A—telencephalic ventricle—schizophrenia	0.00172	0.022	CbGeAlD
Duloxetine—NPY1R—gonad—schizophrenia	0.00169	0.0216	CbGeAlD
Duloxetine—HTR2A—urine—schizophrenia	0.00157	0.0201	CbGeAlD
Duloxetine—HTR6—forebrain—schizophrenia	0.00155	0.0198	CbGeAlD
Duloxetine—SLC6A4—blood plasma—schizophrenia	0.00155	0.0198	CbGeAlD
Duloxetine—HTR2A—pineal body—schizophrenia	0.00149	0.0191	CbGeAlD
Duloxetine—NPY1R—blood—schizophrenia	0.00147	0.0188	CbGeAlD
Duloxetine—CYP2D6—urine—schizophrenia	0.00143	0.0183	CbGeAlD
Duloxetine—HTR6—telencephalon—schizophrenia	0.00142	0.0182	CbGeAlD
Duloxetine—NPY1R—endocrine gland—schizophrenia	0.00127	0.0163	CbGeAlD
Duloxetine—NPY1R—nervous system—schizophrenia	0.00119	0.0153	CbGeAlD
Duloxetine—NPY1R—central nervous system—schizophrenia	0.00115	0.0147	CbGeAlD
Duloxetine—CYP1A2—blood plasma—schizophrenia	0.00105	0.0134	CbGeAlD
Duloxetine—SLC6A3—forebrain—schizophrenia	0.000924	0.0119	CbGeAlD
Duloxetine—NPY1R—brain—schizophrenia	0.000912	0.0117	CbGeAlD
Duloxetine—HTR2C—forebrain—schizophrenia	0.000893	0.0115	CbGeAlD
Duloxetine—SLC6A3—telencephalon—schizophrenia	0.00085	0.0109	CbGeAlD
Duloxetine—SLC6A4—forebrain—schizophrenia	0.000847	0.0109	CbGeAlD
Duloxetine—HTR6—nervous system—schizophrenia	0.000839	0.0108	CbGeAlD
Duloxetine—HTR2C—telencephalon—schizophrenia	0.000822	0.0105	CbGeAlD
Duloxetine—HTR2A—blood plasma—schizophrenia	0.000818	0.0105	CbGeAlD
Duloxetine—HTR6—central nervous system—schizophrenia	0.000808	0.0104	CbGeAlD
Duloxetine—SLC6A4—telencephalon—schizophrenia	0.000779	0.00999	CbGeAlD
Duloxetine—SLC6A2—forebrain—schizophrenia	0.000746	0.00957	CbGeAlD
Duloxetine—CYP2D6—blood plasma—schizophrenia	0.000745	0.00956	CbGeAlD
Duloxetine—SLC6A2—telencephalon—schizophrenia	0.000686	0.0088	CbGeAlD
Duloxetine—HTR6—brain—schizophrenia	0.000642	0.00823	CbGeAlD
Duloxetine—SLC6A3—midbrain—schizophrenia	0.00061	0.00783	CbGeAlD
Duloxetine—HTR2C—midbrain—schizophrenia	0.00059	0.00757	CbGeAlD
Duloxetine—SLC6A2—gonad—schizophrenia	0.000572	0.00734	CbGeAlD
Duloxetine—SLC6A4—blood—schizophrenia	0.000566	0.00727	CbGeAlD
Duloxetine—SLC6A4—midbrain—schizophrenia	0.000559	0.00718	CbGeAlD
Duloxetine—SLC6A3—nervous system—schizophrenia	0.000502	0.00644	CbGeAlD
Duloxetine—SLC6A4—endocrine gland—schizophrenia	0.000491	0.0063	CbGeAlD
Duloxetine—HTR2C—nervous system—schizophrenia	0.000485	0.00622	CbGeAlD
Duloxetine—SLC6A3—central nervous system—schizophrenia	0.000483	0.0062	CbGeAlD
Duloxetine—SLC6A3—cerebellum—schizophrenia	0.000472	0.00606	CbGeAlD
Duloxetine—HTR2C—central nervous system—schizophrenia	0.000467	0.00599	CbGeAlD
Duloxetine—SLC6A4—nervous system—schizophrenia	0.00046	0.0059	CbGeAlD
Duloxetine—HTR2A—forebrain—schizophrenia	0.000448	0.00575	CbGeAlD
Duloxetine—SLC6A4—central nervous system—schizophrenia	0.000443	0.00568	CbGeAlD
Duloxetine—SLC6A2—endocrine gland—schizophrenia	0.000432	0.00555	CbGeAlD
Duloxetine—HTR2A—telencephalon—schizophrenia	0.000412	0.00529	CbGeAlD
Duloxetine—CYP2D6—forebrain—schizophrenia	0.000408	0.00524	CbGeAlD
Duloxetine—SLC6A2—nervous system—schizophrenia	0.000405	0.00519	CbGeAlD
Duloxetine—Atomoxetine—HTR6—schizophrenia	0.000401	0.0856	CrCbGaD
Duloxetine—SLC6A2—central nervous system—schizophrenia	0.00039	0.005	CbGeAlD
Duloxetine—SLC6A3—brain—schizophrenia	0.000384	0.00492	CbGeAlD
Duloxetine—CYP1A2—blood—schizophrenia	0.000383	0.00492	CbGeAlD
Duloxetine—CYP2D6—telencephalon—schizophrenia	0.000375	0.00482	CbGeAlD
Duloxetine—HTR2C—brain—schizophrenia	0.000371	0.00476	CbGeAlD
Duloxetine—SLC6A4—brain—schizophrenia	0.000351	0.00451	CbGeAlD
Duloxetine—Protriptyline—SLC6A4—schizophrenia	0.00035	0.0747	CrCbGaD
Duloxetine—HTR2A—gonad—schizophrenia	0.000344	0.00441	CbGeAlD
Duloxetine—Cinacalcet—CYP1A2—schizophrenia	0.00034	0.0727	CrCbGaD
Duloxetine—CYP1A2—endocrine gland—schizophrenia	0.000332	0.00427	CbGeAlD
Duloxetine—SLC6A2—brain—schizophrenia	0.000309	0.00397	CbGeAlD
Duloxetine—HTR2A—blood—schizophrenia	0.0003	0.00385	CbGeAlD
Duloxetine—HTR2A—midbrain—schizophrenia	0.000296	0.0038	CbGeAlD
Duloxetine—Fluoxetine—HTR2C—schizophrenia	0.000288	0.0616	CrCbGaD
Duloxetine—CYP2D6—blood—schizophrenia	0.000273	0.0035	CbGeAlD
Duloxetine—Cinacalcet—CYP2D6—schizophrenia	0.000263	0.0561	CrCbGaD
Duloxetine—HTR2A—endocrine gland—schizophrenia	0.00026	0.00334	CbGeAlD
Duloxetine—Protriptyline—CYP2D6—schizophrenia	0.000246	0.0525	CrCbGaD
Duloxetine—HTR2A—nervous system—schizophrenia	0.000243	0.00312	CbGeAlD
Duloxetine—Fluoxetine—SLC6A4—schizophrenia	0.000239	0.051	CrCbGaD
Duloxetine—CYP2D6—endocrine gland—schizophrenia	0.000237	0.00304	CbGeAlD
Duloxetine—HTR2A—central nervous system—schizophrenia	0.000234	0.00301	CbGeAlD
Duloxetine—HTR2A—cerebellum—schizophrenia	0.000229	0.00294	CbGeAlD
Duloxetine—Atomoxetine—HTR1B—schizophrenia	0.000227	0.0485	CrCbGaD
Duloxetine—CYP2D6—nervous system—schizophrenia	0.000222	0.00284	CbGeAlD
Duloxetine—Fluoxetine—CYP1A2—schizophrenia	0.000217	0.0464	CrCbGaD
Duloxetine—Propranolol—HTR1B—schizophrenia	0.000216	0.0461	CrCbGaD
Duloxetine—CYP2D6—central nervous system—schizophrenia	0.000213	0.00274	CbGeAlD
Duloxetine—CYP2D6—cerebellum—schizophrenia	0.000209	0.00268	CbGeAlD
Duloxetine—Atomoxetine—SLC6A3—schizophrenia	0.000205	0.0438	CrCbGaD
Duloxetine—HTR2A—brain—schizophrenia	0.000186	0.00239	CbGeAlD
Duloxetine—Atomoxetine—HTR2C—schizophrenia	0.000185	0.0395	CrCbGaD
Duloxetine—Fluoxetine—HTR2A—schizophrenia	0.000183	0.0392	CrCbGaD
Duloxetine—Protriptyline—ABCB1—schizophrenia	0.000175	0.0375	CrCbGaD
Duloxetine—Propranolol—HTR1A—schizophrenia	0.000171	0.0365	CrCbGaD
Duloxetine—CYP2D6—brain—schizophrenia	0.000169	0.00217	CbGeAlD
Duloxetine—Fluoxetine—CYP2D6—schizophrenia	0.000168	0.0358	CrCbGaD
Duloxetine—Atomoxetine—SLC6A4—schizophrenia	0.000153	0.0328	CrCbGaD
Duloxetine—Propranolol—CYP1A2—schizophrenia	0.000133	0.0283	CrCbGaD
Duloxetine—Fluoxetine—ABCB1—schizophrenia	0.00012	0.0256	CrCbGaD
Duloxetine—Atomoxetine—HTR2A—schizophrenia	0.000118	0.0252	CrCbGaD
Duloxetine—Atomoxetine—CYP2D6—schizophrenia	0.000108	0.023	CrCbGaD
Duloxetine—Propranolol—CYP2D6—schizophrenia	0.000102	0.0219	CrCbGaD
Duloxetine—Propranolol—ABCB1—schizophrenia	7.31e-05	0.0156	CrCbGaD
Duloxetine—HTR2C—Signaling by GPCR—NPS—schizophrenia	1.71e-05	0.00014	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—HTR6—schizophrenia	1.69e-05	0.000138	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—PDE4B—schizophrenia	1.68e-05	0.000137	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—DRD1—schizophrenia	1.68e-05	0.000137	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—HTR1A—schizophrenia	1.66e-05	0.000136	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—CNR1—schizophrenia	1.66e-05	0.000135	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CCKAR—schizophrenia	1.66e-05	0.000135	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—NDST3—schizophrenia	1.65e-05	0.000135	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—NPS—schizophrenia	1.64e-05	0.000134	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—MAG—schizophrenia	1.64e-05	0.000134	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—NGEF—schizophrenia	1.63e-05	0.000133	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—DRD3—schizophrenia	1.62e-05	0.000133	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—NPY—schizophrenia	1.62e-05	0.000133	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—HTR7—schizophrenia	1.62e-05	0.000132	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—DRD2—schizophrenia	1.62e-05	0.000132	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—ADORA2A—schizophrenia	1.61e-05	0.000131	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—HTR2C—schizophrenia	1.6e-05	0.000131	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—DRD1—schizophrenia	1.6e-05	0.000131	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—MPC2—schizophrenia	1.6e-05	0.00013	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—NTS—schizophrenia	1.59e-05	0.00013	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—PLA2G4A—schizophrenia	1.58e-05	0.000129	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—DRD4—schizophrenia	1.58e-05	0.000129	CbGpPWpGaD
Duloxetine—SLC6A3—Transmembrane transport of small molecules—APOA1—schizophrenia	1.57e-05	0.000128	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—OXT—schizophrenia	1.57e-05	0.000128	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—HTR1B—schizophrenia	1.57e-05	0.000128	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—ACSL6—schizophrenia	1.56e-05	0.000128	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—SLC27A5—schizophrenia	1.56e-05	0.000128	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—DRD3—schizophrenia	1.55e-05	0.000127	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—FGA—schizophrenia	1.54e-05	0.000126	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—HTR2A—schizophrenia	1.54e-05	0.000126	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—HTR1A—schizophrenia	1.51e-05	0.000123	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—DRD4—schizophrenia	1.51e-05	0.000123	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—CNR1—schizophrenia	1.51e-05	0.000123	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—ATP2A2—schizophrenia	1.5e-05	0.000122	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—NOTCH4—schizophrenia	1.5e-05	0.000122	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—NPY—schizophrenia	1.5e-05	0.000122	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—RTN4—schizophrenia	1.5e-05	0.000122	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—RGS4—schizophrenia	1.5e-05	0.000122	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—GRM3—schizophrenia	1.5e-05	0.000122	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CHRM1—schizophrenia	1.5e-05	0.000122	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—DAO—schizophrenia	1.49e-05	0.000122	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism of lipids and lipoproteins—CLOCK—schizophrenia	1.49e-05	0.000122	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—NPS—schizophrenia	1.49e-05	0.000121	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—PLCH2—schizophrenia	1.49e-05	0.000121	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—HTR6—schizophrenia	1.47e-05	0.00012	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—HTR7—schizophrenia	1.47e-05	0.00012	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—DRD2—schizophrenia	1.47e-05	0.00012	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—IL3RA—schizophrenia	1.46e-05	0.000119	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—DRD1—schizophrenia	1.46e-05	0.000119	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—HTR2C—schizophrenia	1.46e-05	0.000119	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—OXT—schizophrenia	1.45e-05	0.000118	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—HTR1B—schizophrenia	1.45e-05	0.000118	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—CNR1—schizophrenia	1.44e-05	0.000118	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—PNP—schizophrenia	1.43e-05	0.000117	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—NRG3—schizophrenia	1.42e-05	0.000116	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—TLE1—schizophrenia	1.42e-05	0.000116	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—MAG—schizophrenia	1.42e-05	0.000116	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—DRD3—schizophrenia	1.41e-05	0.000115	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—GFAP—schizophrenia	1.41e-05	0.000115	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—DRD2—schizophrenia	1.41e-05	0.000115	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—HTR7—schizophrenia	1.41e-05	0.000115	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—HTR2A—schizophrenia	1.4e-05	0.000114	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—NDST3—schizophrenia	1.4e-05	0.000114	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—HTR1A—schizophrenia	1.39e-05	0.000114	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—GRM5—schizophrenia	1.39e-05	0.000114	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—NPS—schizophrenia	1.37e-05	0.000112	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—DRD4—schizophrenia	1.37e-05	0.000112	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—TLE3—schizophrenia	1.35e-05	0.00011	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—DRD1—schizophrenia	1.35e-05	0.00011	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—HTR2C—schizophrenia	1.35e-05	0.00011	CbGpPWpGaD
Duloxetine—NPY1R—GPCR downstream signaling—AKT1—schizophrenia	1.34e-05	0.000109	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—NDUFV2—schizophrenia	1.33e-05	0.000108	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—SLC27A5—schizophrenia	1.32e-05	0.000108	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—ACSL6—schizophrenia	1.32e-05	0.000108	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—NTRK2—schizophrenia	1.31e-05	0.000107	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—CNR1—schizophrenia	1.31e-05	0.000107	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—DRD3—schizophrenia	1.3e-05	0.000106	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CHRM1—schizophrenia	1.3e-05	0.000106	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3C2A—schizophrenia	1.29e-05	0.000106	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—DRD2—schizophrenia	1.28e-05	0.000104	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—HTR7—schizophrenia	1.28e-05	0.000104	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CCK—schizophrenia	1.27e-05	0.000104	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—IL3RA—schizophrenia	1.27e-05	0.000103	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—DRD4—schizophrenia	1.27e-05	0.000103	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—DAO—schizophrenia	1.26e-05	0.000103	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—PIP4K2A—schizophrenia	1.25e-05	0.000102	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—PDE4B—schizophrenia	1.24e-05	0.000101	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—NRG3—schizophrenia	1.24e-05	0.000101	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—TLE1—schizophrenia	1.24e-05	0.000101	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—GFAP—schizophrenia	1.22e-05	9.97e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CCKAR—schizophrenia	1.22e-05	9.96e-05	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—AKT1—schizophrenia	1.21e-05	9.9e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—PNP—schizophrenia	1.21e-05	9.89e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CNR1—schizophrenia	1.21e-05	9.86e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—GRM5—schizophrenia	1.21e-05	9.86e-05	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—EP300—schizophrenia	1.19e-05	9.68e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—ADORA2A—schizophrenia	1.18e-05	9.66e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—HTR7—schizophrenia	1.18e-05	9.62e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—DRD2—schizophrenia	1.18e-05	9.62e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—TLE3—schizophrenia	1.17e-05	9.55e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—PLA2G4A—schizophrenia	1.16e-05	9.49e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—FGA—schizophrenia	1.13e-05	9.26e-05	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—HTR2A—schizophrenia	1.13e-05	9.25e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—CYP26B1—schizophrenia	1.13e-05	9.22e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—NDUFV2—schizophrenia	1.13e-05	9.19e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—PRL—schizophrenia	1.11e-05	9.09e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—NPY—schizophrenia	1.11e-05	9.02e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—NOTCH4—schizophrenia	1.11e-05	9.02e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—ATP2A2—schizophrenia	1.11e-05	9.02e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CCK—schizophrenia	1.1e-05	9.02e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—PDE4B—schizophrenia	1.08e-05	8.79e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—HTR1B—schizophrenia	1.07e-05	8.7e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—OXT—schizophrenia	1.07e-05	8.7e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CCKAR—schizophrenia	1.06e-05	8.65e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—PIP4K2A—schizophrenia	1.06e-05	8.64e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—S100B—schizophrenia	1.04e-05	8.47e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—HTR2A—schizophrenia	1.03e-05	8.4e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—ADORA2A—schizophrenia	1.03e-05	8.38e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—HTR1A—schizophrenia	1.03e-05	8.38e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—NPS—schizophrenia	1.01e-05	8.25e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—PLA2G4A—schizophrenia	1.01e-05	8.24e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—TPH1—schizophrenia	1.01e-05	8.22e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—GCLM—schizophrenia	1.01e-05	8.22e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—ERBB4—schizophrenia	9.92e-06	8.1e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—DRD1—schizophrenia	9.91e-06	8.09e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—FGA—schizophrenia	9.85e-06	8.04e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—NTRK2—schizophrenia	9.64e-06	7.87e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—DRD3—schizophrenia	9.6e-06	7.84e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—NPY—schizophrenia	9.6e-06	7.83e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—NOTCH4—schizophrenia	9.6e-06	7.83e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—ATP2A2—schizophrenia	9.6e-06	7.83e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—CYP26B1—schizophrenia	9.57e-06	7.81e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—PRKD1—schizophrenia	9.47e-06	7.73e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—PLA2G4A—schizophrenia	9.33e-06	7.62e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—DRD4—schizophrenia	9.32e-06	7.61e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—HTR1B—schizophrenia	9.26e-06	7.56e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—OXT—schizophrenia	9.26e-06	7.56e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—NRG1—schizophrenia	9.16e-06	7.48e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—MEF2C—schizophrenia	9.08e-06	7.41e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—HTR1A—schizophrenia	8.91e-06	7.28e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CNR1—schizophrenia	8.9e-06	7.26e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—NPS—schizophrenia	8.78e-06	7.16e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—YWHAZ—schizophrenia	8.77e-06	7.16e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—HTR7—schizophrenia	8.68e-06	7.09e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—DRD2—schizophrenia	8.68e-06	7.09e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—DRD1—schizophrenia	8.61e-06	7.03e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—HTR2C—schizophrenia	8.61e-06	7.03e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—ERBB3—schizophrenia	8.58e-06	7e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—GCLM—schizophrenia	8.53e-06	6.97e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—TPH1—schizophrenia	8.53e-06	6.97e-05	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—TP53—schizophrenia	8.49e-06	6.93e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—NTRK2—schizophrenia	8.37e-06	6.84e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—DRD3—schizophrenia	8.34e-06	6.8e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—HTR2A—schizophrenia	8.26e-06	6.74e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—PRL—schizophrenia	8.2e-06	6.69e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—DRD4—schizophrenia	8.09e-06	6.61e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—schizophrenia	8.05e-06	6.57e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—PRKD1—schizophrenia	8.02e-06	6.55e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—GAPDH—schizophrenia	7.9e-06	6.45e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—CLOCK—schizophrenia	7.83e-06	6.39e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CNR1—schizophrenia	7.73e-06	6.31e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—APOE—schizophrenia	7.68e-06	6.27e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—S100B—schizophrenia	7.64e-06	6.24e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—CACNB2—schizophrenia	7.63e-06	6.23e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—TPH2—schizophrenia	7.63e-06	6.23e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—APOA1—schizophrenia	7.59e-06	6.19e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—HTR7—schizophrenia	7.54e-06	6.15e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—DRD2—schizophrenia	7.54e-06	6.15e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—DPYD—schizophrenia	7.51e-06	6.13e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—ESR1—schizophrenia	7.33e-06	5.98e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—ERBB4—schizophrenia	7.31e-06	5.97e-05	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—AKT1—schizophrenia	7.17e-06	5.85e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—PRL—schizophrenia	7.12e-06	5.81e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—CACNA1C—schizophrenia	6.98e-06	5.7e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—PLA2G4A—schizophrenia	6.87e-06	5.61e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—PIK3C2A—schizophrenia	6.8e-06	5.55e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—NRG1—schizophrenia	6.74e-06	5.51e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—GAPDH—schizophrenia	6.7e-06	5.47e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—MEF2C—schizophrenia	6.68e-06	5.46e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—GSK3B—schizophrenia	6.65e-06	5.43e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—CLOCK—schizophrenia	6.64e-06	5.42e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—S100B—schizophrenia	6.63e-06	5.42e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—schizophrenia	6.62e-06	5.4e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	6.54e-06	5.34e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—TPH2—schizophrenia	6.47e-06	5.28e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—CACNB2—schizophrenia	6.47e-06	5.28e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—YWHAZ—schizophrenia	6.46e-06	5.27e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—DPYD—schizophrenia	6.36e-06	5.19e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—ERBB4—schizophrenia	6.35e-06	5.18e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—ERBB3—schizophrenia	6.32e-06	5.16e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—SNAP25—schizophrenia	6.1e-06	4.98e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—HTR2A—schizophrenia	6.08e-06	4.96e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—PLA2G4A—schizophrenia	5.97e-06	4.87e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—CACNA1C—schizophrenia	5.91e-06	4.83e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—NRG1—schizophrenia	5.86e-06	4.78e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—MEF2C—schizophrenia	5.8e-06	4.74e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—PIK3C2A—schizophrenia	5.76e-06	4.71e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—APOE—schizophrenia	5.65e-06	4.61e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—YWHAZ—schizophrenia	5.61e-06	4.58e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—APOA1—schizophrenia	5.59e-06	4.56e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—CYP1A2—schizophrenia	5.52e-06	4.51e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—ERBB3—schizophrenia	5.49e-06	4.48e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—TH—schizophrenia	5.44e-06	4.44e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—ESR1—schizophrenia	5.4e-06	4.41e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—CYP2D6—schizophrenia	5.17e-06	4.22e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—SNAP25—schizophrenia	5.17e-06	4.22e-05	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—AKT1—schizophrenia	4.93e-06	4.02e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—APOE—schizophrenia	4.91e-06	4.01e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—GSK3B—schizophrenia	4.9e-06	4e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—APOA1—schizophrenia	4.85e-06	3.96e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—ESR1—schizophrenia	4.69e-06	3.83e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—COMT—schizophrenia	4.62e-06	3.78e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—TH—schizophrenia	4.61e-06	3.76e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—GSTP1—schizophrenia	4.6e-06	3.76e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—MAOA—schizophrenia	4.59e-06	3.75e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—AKT1—schizophrenia	4.47e-06	3.65e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—EP300—schizophrenia	4.37e-06	3.57e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—ABCB1—schizophrenia	4.36e-06	3.56e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—GSK3B—schizophrenia	4.25e-06	3.47e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—GSTM1—schizophrenia	4.23e-06	3.45e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—PLA2G4A—schizophrenia	4.23e-06	3.45e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—COMT—schizophrenia	3.92e-06	3.2e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—GSTP1—schizophrenia	3.9e-06	3.18e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—MAOA—schizophrenia	3.89e-06	3.18e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—schizophrenia	3.77e-06	3.08e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—MTHFR—schizophrenia	3.74e-06	3.05e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—ABCB1—schizophrenia	3.69e-06	3.01e-05	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—AKT1—schizophrenia	3.63e-06	2.96e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—PLA2G4A—schizophrenia	3.58e-06	2.93e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—GSTM1—schizophrenia	3.58e-06	2.93e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—APOE—schizophrenia	3.48e-06	2.84e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—APOA1—schizophrenia	3.44e-06	2.81e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—AKT1—schizophrenia	3.3e-06	2.69e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—EP300—schizophrenia	3.22e-06	2.63e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—MTHFR—schizophrenia	3.17e-06	2.59e-05	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—AKT1—schizophrenia	3.15e-06	2.57e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—TP53—schizophrenia	3.13e-06	2.56e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—APOE—schizophrenia	2.95e-06	2.41e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—APOA1—schizophrenia	2.91e-06	2.38e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—AKT1—schizophrenia	2.86e-06	2.34e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—EP300—schizophrenia	2.8e-06	2.28e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—AKT1—schizophrenia	2.64e-06	2.16e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—TP53—schizophrenia	2.31e-06	1.88e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—TP53—schizophrenia	2e-06	1.63e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—EP300—schizophrenia	1.98e-06	1.62e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—AKT1—schizophrenia	1.95e-06	1.59e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—AKT1—schizophrenia	1.69e-06	1.38e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—EP300—schizophrenia	1.68e-06	1.37e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—AKT1—schizophrenia	1.2e-06	9.78e-06	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—AKT1—schizophrenia	1.02e-06	8.29e-06	CbGpPWpGaD
